Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore (Companion Faculty Lecture)
Research To Practice | Oncology Videos · Dr. Neil Love
February 9, 202636m 5s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation and related discussion from Dr Kathleen N Moore, including the following topics:
- Overview of developments and opportunities with antibody-drug conjugates (ADCs) in ovarian cancer(0:00)
- Targeting folate receptor alpha with mirvetuximab soravtansine (3:59)
- Targeting TROP2 with ADCs (9:12)
- Targeting folate receptor alpha with ADCs (14:17)
- Targeting cadherin-6 with ADCs (17:27)
- Targeting HER2 with ADCs (26:12)
- Potential of ADCs in the treatment of platinum-sensitive ovarian cancer (28:38)